Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery

Eye and Contact Lens

Volumn 34, Issue 1, 2008, Pages 39-42

  Bucci Jr , Frank A ^a   Amico, Loretta M ^a   Evans, Ruth E ^a  

^a Bucci Laser Vision Institute   (United States)

Author keywords

Antibiotic; Antiinfective; Cataract; Infection; Prophylaxis

Indexed keywords

GATIFLOXACIN; MOXIFLOXACIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; AQUEOUS HUMOR; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; COLONY FORMING UNIT; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EYE INFECTION; EYELID; HUMAN; HUMAN TISSUE; PHACOEMULSIFICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTITUBERCULAR AGENTS; AQUEOUS HUMOR; AZA COMPOUNDS; CONJUNCTIVA; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE INFECTIONS, BACTERIAL; EYELIDS; FLUOROQUINOLONES; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; QUINOLINES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 38049005114     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICL.0b013e3180645d01     Document Type: Article

References (14)

1. Cosar CB, Cohen EJ, Rapuano CJ, et al. Clear corneal wound infection after phacoemulsification. Arch Ophthalmol 2001;119:1755-1759.
2. McDonnell PJ, Taban M, Sarayba M, et al. Dynamic morphology of clear corneal cataract incisions. Ophthalmology 2003;110:2342-2348.
3. Cooper BA, Holekamp NM, Bohigian G, et al. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear cornea wounds. Am J Ophthalmol 2003;136:300-305.
4. Leong JK, Shah R, McCluskey PJ, et al. Bacterial contamination of the anterior chamber during phacoemulsification cataract surgery. J Cataract Refract Surg 2002;28:826-833.
5. Blondeau JM. Fluoroquinolones: Mechanism of action, classification, and development of resistance. Surv Ophthalmol 2004;49(suppl 2):S73-S78.
6. Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 2004;49(suppl 2):S79-S83.
7. Mather R, Karenchak LM, Romanowski EG, et al. Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463-466.
8. Cole R. Bacterial contamination rate of aqueous humor after 3-day prophylaxis with gatifloxacin 0.3% prior to cataract surgery. Presented at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS), Washington, DC, April 15-20, 2005.
9. Manners TD, Chitkara DK, Marsh PJ, et al. Anterior chamber aspirate cultures in small incision cataract surgery. Br J Ophthalmol 1995;79:878-880.
10. Beigi B, Westlake W, Mangelschots E, et al. Peroperative microbial contamination of anterior chamber aspirates during extracapsular cataract extraction and phacoemulsification. Br J Ophthalmol 1997;81:953-955.
11. Beigi B, Westlake W, Chang B, et al. The effect of intracameral, per-operative antibiotics on microbial contamination of anterior chamber aspirates during phacoemulsification. Eye 1998;12:390-394.
12. Srinivasan R, Tiroumal S, Kanungo R, et al. Microbial contamination of the anterior chamber during phacoemulsification. J Cataract Refract Surg 2002;28:2173-2176.
13. McCulley JP, Caudle D, Aronowicz JD, et al. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. Ophthalmology 2006;113:955-959.
14. Price MO, Quillin C, Price FW Jr. Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration. Curr Eye Res 2005;30:563-567.